Satellite Banner
Technology Networks Header
Sunday, September 21, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bespoke Instrumentation and Custom Manufacturing from Bibby Scientific
Wednesday, May 14, 2014
The company can produce solutions which directly meet with customer specs, ensuring that they get the results they require in the most accurate and reliable way possible.

Exiqon Launches XploreRNA™ app for Advanced Cross-Database Queries
Tuesday, May 13, 2014
XploreRNA™ will soon be available on Android and Windows platforms.

Bio-Rad Introduces New CytoTrack™ Cell Proliferation Assays
Saturday, May 10, 2014
Easy, longer-lasting staining of live cells for multicolor flow cytometry experiments.

Exiqon Launches Exosome Isolation Kits for Analysis of Biofluids
Thursday, May 08, 2014
miRCURY™ Exosome Isolation kits ensure exosomes recovery in less than two hours.

Fluxion Biosciences Introduces IsoFlux™ NGS Assay Kits
Tuesday, April 22, 2014
New kits enable mutation detection from circulating tumor cells using next-generation sequencing.

Malvern Reports on the Publication of the 1000th Peer-reviewed Paper to Cite NanoSight’s NTA
Wednesday, April 16, 2014
Nanoparticle Tracking Analysis made measuring size easier and more accurate.

Molecular Devices to Attend Fourth Annual European Lab Automation (ELA) 2014
Wednesday, April 16, 2014
Molecular Devices® will be showcasing the next generation SpectraMax® MiniMax™ 300 imaging cytometer.

Life Technologies Releases New Research Tool
Tuesday, April 08, 2014
Oncomine NGS RNA-Seq Gene Expression Browser extends the Oncomine NGS Power Tools product offering.

Eppendorf Launches its New Spring 2014 Advantage Offer
Saturday, April 05, 2014
New offer enables customers to purchase products at favourable prices.

<< 1 2 3 4 5 6 7 >>
Showing Results 21 - 30 of 713
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv